SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(McLean C) "

Search: WFRF:(McLean C)

  • Result 51-60 of 151
Sort/group result
   
EnumerationReferenceCoverFind
51.
  •  
52.
  •  
53.
  • Hollestelle, Antoinette, et al. (author)
  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
  • 2016
  • In: Gynecologic Oncology. - : Elsevier BV. - 0090-8258 .- 1095-6859. ; 141:2, s. 386-401
  • Journal article (peer-reviewed)abstract
    • Objective Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3′ UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with survival time. However, prior studies, emphasizing particular subgroups, were relatively small. Therefore, we comprehensively evaluated ovarian and breast cancer risks as well as clinical outcome associated with rs61764370. Methods Centralized genotyping and analysis were performed for 140,012 women enrolled in the Ovarian Cancer Association Consortium (15,357 ovarian cancer patients; 30,816 controls), the Breast Cancer Association Consortium (33,530 breast cancer patients; 37,640 controls), and the Consortium of Modifiers of BRCA1 and BRCA2 (14,765 BRCA1 and 7904 BRCA2 mutation carriers). Results We found no association with risk of ovarian cancer (OR = 0.99, 95% CI 0.94-1.04, p = 0.74) or breast cancer (OR = 0.98, 95% CI 0.94-1.01, p = 0.19) and results were consistent among mutation carriers (BRCA1, ovarian cancer HR = 1.09, 95% CI 0.97-1.23, p = 0.14, breast cancer HR = 1.04, 95% CI 0.97-1.12, p = 0.27; BRCA2, ovarian cancer HR = 0.89, 95% CI 0.71-1.13, p = 0.34, breast cancer HR = 1.06, 95% CI 0.94-1.19, p = 0.35). Null results were also obtained for associations with overall survival following ovarian cancer (HR = 0.94, 95% CI 0.83-1.07, p = 0.38), breast cancer (HR = 0.96, 95% CI 0.87-1.06, p = 0.38), and all other previously-reported associations. Conclusions rs61764370 is not associated with risk of ovarian or breast cancer nor with clinical outcome for patients with these cancers. Therefore, genotyping this variant has no clinical utility related to the prediction or management of these cancers.
  •  
54.
  •  
55.
  •  
56.
  •  
57.
  •  
58.
  •  
59.
  •  
60.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 51-60 of 151
Type of publication
journal article (134)
conference paper (6)
research review (3)
book chapter (2)
Type of content
peer-reviewed (134)
other academic/artistic (11)
Author/Editor
Brenner, H (45)
Wang, Q. (40)
Fasching, PA (38)
Cox, A (38)
Chang-Claude, J (38)
Czene, K (37)
show more...
Giles, GG (37)
Bojesen, SE (37)
Milne, RL (36)
Southey, MC (36)
Schmidt, MK (36)
Mannermaa, A (36)
Kosma, VM (36)
Garcia-Closas, M (36)
Chenevix-Trench, G (36)
Hall, P (35)
Margolin, S (35)
Hopper, JL (35)
Dunning, AM (35)
Beckmann, MW (35)
Couch, FJ (35)
Burwinkel, B (35)
Nevanlinna, H (35)
Easton, DF (35)
Benitez, J. (34)
Andrulis, IL (34)
Winqvist, R (34)
Lindblom, A (33)
Peterlongo, P (33)
Hamann, U (33)
Nordestgaard, BG (33)
Hooning, MJ (33)
Blomqvist, C (32)
Brauch, H (32)
Haiman, CA (32)
Lubinski, J (32)
Aittomaki, K (32)
Dork, T (32)
Bolla, MK (31)
Knight, JA (31)
Arndt, V (31)
Lambrechts, D (31)
Jakubowska, A (31)
Anton-Culver, H (30)
Tomlinson, I (30)
Ekici, AB (30)
Flesch-Janys, D (30)
Pylkas, K (30)
Devilee, P (30)
Tollenaar, RAEM (30)
show less...
University
Karolinska Institutet (98)
Lund University (38)
Uppsala University (35)
University of Gothenburg (26)
Umeå University (25)
University of Skövde (7)
show more...
Linköping University (6)
Royal Institute of Technology (5)
Högskolan Dalarna (4)
Luleå University of Technology (3)
Stockholm University (3)
Chalmers University of Technology (3)
Linnaeus University (3)
Swedish University of Agricultural Sciences (2)
Örebro University (1)
Jönköping University (1)
Marie Cederschiöld högskola (1)
show less...
Language
English (151)
Research subject (UKÄ/SCB)
Medical and Health Sciences (76)
Natural sciences (16)
Social Sciences (11)
Engineering and Technology (2)
Humanities (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view